Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
CIPL | NSE | INR | Real-time | |
CIPLc1:NS | NSE | INR | Delayed | |
CIPLc2:NS | NSE | INR | Delayed | |
CIPLc3:NS | NSE | INR | Delayed | |
CIPL | BSE | INR | Delayed |
Cipla Limited, together with its subsidiaries, manufactures, develops, and sells pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New ventures segments. It also offers active pharmaceutical ingredients; and formulations in various therapeutic areas, such as MI, angina, heart failure, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, HIV, respiratory, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women’s health, ophthalmology, and neuro psychiatry. In addition, the company provides respiratory products, including inhalers and nasal sprays, as well as other respiratory products consists of injectables and biosimilars. Further, it offers Easylax and Easylax L, a liquid paraffin for constipation. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.
Name | Age | Since | Title |
---|---|---|---|
Mustafa Khwaja Hamied | 81 | 1977 | Non-Executive Vice-Chairman |
Yusuf Khwaja Hamied | 85 | 1972 | Non-Executive Chairman |
Umang Vohra | 50 | 2015 | MD, Global CEO & Executive Director |
Adil Siraj Zainulbhai | 69 | 2014 | Lead Independent Non-Executive Director |
Ashok U. Sinha | 72 | 2013 | Independent Non-Executive Director |
S. Radhakrishnan | 67 | 2010 | Non-Executive Non-Independent Director |
Prathivadibhayankara Rajagopalan Ramesh | 68 | 2021 | Independent Director |
Robert A. Stewart | 56 | 2021 | Independent Director |
Samina Hamied | 48 | 2015 | Non-Executive Director |
Punita Lal | 62 | 2014 | Independent Non-Executive Director |
Mandar Purushottam Vaidya | 48 | 2022 | Independent Director |
Balram Bhargava | - | 2024 | Additional & Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review